Disclosure Of Interests In Other Entities [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183075

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	Filiales	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	- EUR	—	—	—	—	—	—	- EUR	—	—
Current assets	145 863 EUR	—	—	—	—	—	99 389 EUR	—	—	—	—	—	—
Non-current assets	296 552 EUR	—	—	—	—	—	322 528 EUR	—	—	—	—	—	—
Current liabilities	130 431 EUR	—	—	—	—	—	95 793 EUR	—	—	—	—	—	—
Non-current liabilities	278 298 EUR	—	—	—	—	—	292 285 EUR	—	—	—	—	—	—
Revenue	—	—	—	66,997,000 EUR	—	—	—	—	—	—	22,668,000 EUR	—	—
Profit (loss)	—	—	—	59 620 EUR	59 620 EUR	—	—	—	—	—	116 875 EUR	116 875 EUR	—
Comprehensive income	—	- EUR	18 298 EUR	77 918 EUR	59 620 EUR	- EUR	—	17 300 EUR	- EUR	- EUR	134 175 EUR	116 875 EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	Sociétés liées	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	—	—	—	18 298 EUR	—	—	—	—	—	—	17 300 EUR	—	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	28,285,000 EUR	—	—	—	—	—	32,872,000 EUR	—	—	—	—	—	138,675,000 EUR
Other current financial liabilities	15,959,000 EUR	—	—	—	—	—	15,829,000 EUR	—	—	—	—	—	—
Other non-current financial liabilities	74,210,000 EUR	—	—	—	—	—	102,675,000 EUR	—	—	—	—	—	—
Tax expense (income)	—	—	—	48 139 EUR	—	—	—	—	—	—	6 895 EUR	—	—